- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01779713
Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage
Discovery of the Risk Factors Associated to the Development of Vasospasm Following a Sub-arachnoid Aneurismal Hemorrhage Via Genomic Studies Including Genetic and Transcriptomic
Rational: The main danger with intracranial aneurism is its rupture conjugated with subarachnoid hemorrhage (SAH) occurrence. SAH is a severe pathology leading not only to neurological but also extra cerebral disorders. The major cause of morbidity and mortality when developing a SAH is the secondary development of a delayed cerebral ischemia consecutive to a prolonged vasospasm of cerebral arteries. The understanding of the pathophysiological mechanisms of SAH complication, such as vasospasm which is the more frequent, is essential.
Vasospasm is defined as a reversible shrinking of an artery lumen diameter in the subarachnoid space, beginning generally between 4 and 12 days after the hemorrhage. Such a vasospasm could have a huge clinical impact leading to delayed neurological ischemic deficiency in 17 to 40 % of cases. Up to day, mechanisms involved in vasospasm occurrence are not well described.
Disposing of well-established genetics and transcriptomics databases along with cerebral ischemia and inflammation is essential to unravel the mechanisms leading to vasospasm occurrence on SAH patients. It will enable researchers to better comprehend SAH pathology and elaborate an efficient and individualized therapeutic strategy to SAH acute phase in order to reduce the risk of vasospasm occurrence.
Aims: 1) Constitute DNA and RNA Biobank via blood proofing oh SAH patients 2) Constitute a database grouping clinical and biological data 3) Look for genetic and transcriptomic early markers via genomic approaches 4) Correlate these different markers with vasospasm occurrence and clinical evolution of the patients
Study: Patients inclusion will be done following their admission (D1) in the " unité de réanimation neurochirurgicale" of Pitié-Salpètrière Hospital. After obtaining of the informed consent, blood proofing will be realized daily during 12 days: one daily 2.5ml tube for the transcriptomic study and a single 10ml EDTA tube for genetic analyses. Clinical and biological follow-up will be performed as usual.
200 patients will be initially included during 2 to 3 years for the transcriptomic study of which 1/3 will develop vasospastic complication. The transcriptomic study will thus be performed by comparing patients developing or not developing this complication
Expected Results: Unravel vasospasm early genetic markers.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75013
- Neuro-anesthesia intensive care unit, Pitié-Salpétrière hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient entering the neurosurgical unit in the 48 hours following an aneurismal sub-arachnoid hemorrhage and treated in the 96 first hours (embolization or surgery)
- Aged more than 18
- Caucasian origin
- Affiliated to a social care service
- Having (or one of is related if he is comatose) given its informed consent
Exclusion Criteria:
- Subjects which do not have a social care protection
- Subjects (or one of is related if he is comatose) refusing to sign the consent
- Subjects being under a protective juridical system for adults
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Vasospastic patients
Any patient send to the neuro-anesthesia intensive care unit in the 48 hours following an aneurismal sub-arachnoid hemorrhage and treated in the 96 first hours (embolization or surgery) and developing a vasospasm during the first 12 days after the bleeding; aged more than 18; of Caucasian origin; affiliated to a social care service; having (or one of is related if he is comatose) given its informed consent
|
No intervention
|
Control patients
Any patient send to the neuro-anesthesia intensive care unit in the 48 hours following an aneurismal sub-arachnoid hemorrhage and treated in the 96 first hours (embolization or surgery) not developing a vasospasm during the first 12 days after the bleeding; aged more than 18; of Caucasian origin; affiliated to a social care service; having (or one of is related if he is comatose) given its informed consent
|
No intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evidence of clinically definite vasospasm
Time Frame: Between intensive care unit admission and day twelve
|
Any cases will be reviewed by an expert committee to establish vasospasm diagnosis Diagnosis criteria:
|
Between intensive care unit admission and day twelve
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rankin Score
Time Frame: 6 months and 1 year after ICU discharge
|
6 months and 1 year after ICU discharge
|
Glasgow outcome score (GOS)
Time Frame: 6 months and 1 year after ICU discharge
|
6 months and 1 year after ICU discharge
|
Collaborators and Investigators
Investigators
- Study Director: Sophie Garnier, Lecturer, INSERM and University Pierre and Marie Curie
- Study Chair: Louis Puybasset, MD PhD, Pierre and Marie Curie University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C10-15
- 2012-A00935-38 (Registry Identifier: IDRCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aneurysmal Subarachnoid Hemorrhage
-
Medical University InnsbruckRecruitingSubarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, CerebralAustria
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingSubarachnoid Hemorrhage, Aneurysmal | Subarachnoid Hemorrhage, SpontaneousItaly
-
El Instituto Nacional de Neurologia y Neurocirugia...CompletedBrain Ischemia | Subarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, CerebralMexico
-
IRCCS San RaffaeleFondazione Policlinico Universitario Agostino Gemelli IRCCS; Azienda Ospedaliera... and other collaboratorsRecruitingSubarachnoid Hemorrhage, Aneurysmal | Poor Grade Subarachnoid HemorrhageItaly
-
Hackensack Meridian HealthRecruitingStroke | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Cerebral Aneurysm | Cerebral Ischemia | Vasospasm, CerebralUnited States
-
University of CalgaryUnknownIntraventricular Hemorrhage | Aneurysmal Subarachnoid HemorrhageCanada
-
University of Texas Southwestern Medical CenterRecruitingSubarachnoid Hemorrhage, AneurysmalUnited States
-
Milton S. Hershey Medical CenterRecruiting
-
Second Affiliated Hospital, School of Medicine,...RecruitingSubarachnoid Hemorrhage, AneurysmalChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingAneurysmal Subarachnoid HemorrhageChina
Clinical Trials on Case-control transcriptomic study
-
Gulf Medical UniversityNot yet recruiting
-
Kintampo Health Research Centre, GhanaLondon School of Hygiene and Tropical Medicine; PATH; Kenya Medical Research... and other collaboratorsActive, not recruitingMalariaGhana, Kenya, Malawi
-
Bavarian Cancer RegistryBavarian Association of Statutory Health Insurance Accredited PhysiciansNot yet recruitingNeuroendocrine Neoplasm of Lung | Neuroendocrine Neoplasm of Gastrointestinal Tract (Disorder)
-
King Saud UniversityCompletedObesity | Metabolic SyndromeSaudi Arabia
-
Assiut UniversityRecruitingPseudoexfoliation SyndromeEgypt
-
National Taiwan University HospitalCompletedHospitalization Rate | Mortality Rate | Functional Recovery | Left Ventricle Ejection Fraction | NT-pro BNPTaiwan
-
Assistance Publique - Hôpitaux de ParisCompletedStaphylococcus Aureus | Folliculitis DecalvansFrance
-
Hillel Yaffe Medical CenterUnknown
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA); University of Kentucky; University of... and other collaboratorsCompleted
-
University of PennsylvaniaActive, not recruitingStimulant OverdoseUnited States